Furthermore, the frequency and severity of hematological toxicities were quite comparable between [225Ac]Ac-PSMA and [177Lu]Lu-PSMA PRLT: anemia G3 or higher 11% vs. 10%; leukocytopenia G3 or higher 9% vs. 2%; thrombocytopenia G3 or higher 7% vs. 7%. This evidence concerns the gene FOLH1 and Thrombocytopenia.